Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

CEL-SCI (CVM) announced new data has been published from its prior Phase 3 study of Multikine in newly diagnosed, treatment naive, resectable, ...

The Kingdom of Jordan recently opened its first advanced nuclear medicine diagnostic centre in a public hospital with IAEA support, significantly increasing access to diagnostic services for cancer ...

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year's ...

Professor Chim Lang and Professor Ian Ganley are among a cohort of new Fellows of the Royal Society of Edinburgh (RSE).